Prophylaxis against central vein thrombosis with low-dose warfarin

Area of Science:

• Cardiology
• Hematology
• Pharmacology

Background:

• Venous thrombosis is a risk for patients with central venous catheters.
• The von Kaulla assay identifies patients at high risk for thrombus formation.

Purpose of the Study:

• To evaluate the efficacy of low-dose warfarin in preventing venous thrombosis.
• To assess warfarin's impact on patients with accelerated von Kaulla assays.

Main Methods:

• Administered low-dose warfarin to high-risk patients.
• Utilized the von Kaulla assay to identify at-risk individuals.
• Monitored thrombus incidence in relation to risk stratification.

Main Results:

• Patients with accelerated von Kaulla assays had a higher thrombus incidence (1 per 500 days) compared to normal assays (1 per 1844 days).
• Low-dose warfarin reduced venous thrombosis incidence in high-risk patients from 1 per 251 days to 1 per 1617 days.

Conclusions:

• Low-dose warfarin prophylaxis is effective in preventing venous thrombosis near central venous catheters.
• Warfarin doses that do not prolong prothrombin time offer protection in high-risk patient populations.